These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
713 related items for PubMed ID: 7488238
21. Influence of oral treatment with ursodeoxycholic and tauroursodeoxycholic acids on estrogen-induced cholestasis in rats: effects on bile formation and liver plasma membranes. Bouchard G, Yousef IM, Tuchweber B. Liver; 1993 Aug; 13(4):193-202. PubMed ID: 8377596 [Abstract] [Full Text] [Related]
22. Prevention of Mrp2 activity impairment in ethinylestradiol-induced cholestasis by ursodeoxycholate in the rat. Crocenzi FA, D'Andrea V, Catania VA, Luquita MG, Pellegrino JM, Ochoa JE, Mottino AD, Sánchez Pozzi EJ. Drug Metab Dispos; 2005 Jul; 33(7):888-91. PubMed ID: 15843489 [Abstract] [Full Text] [Related]
23. Selectively reduced biliary excretion of cholyldiglycylhistamine but not of cholyltetraglycylhistamine in ethinyl estradiol-treated rats. A possible indicator of increased bile canalicular permeability. Mills CO, Iqbal S, Elias E. J Hepatol; 1985 Jul; 1(3):199-210. PubMed ID: 4067252 [Abstract] [Full Text] [Related]
24. Hepatoprotection in ethinylestradiol-treated rats is provided by tauroursodeoxycholic acid, but not by ursodeoxycholic acid. Azer SA, Canfield PJ, Stacey NH. J Gastroenterol Hepatol; 1995 Jul; 10(3):261-9. PubMed ID: 7548801 [Abstract] [Full Text] [Related]
25. Effect of alpha-asarone and a derivative on lipids, bile flow and Na+/K+-ATPase in ethinyl estradiol-induced cholestasis in the rat. Garduño-Siciliano L, Labarrios F, Tamariz J, Moreno MG, Chamorro G, Muriel P. Fundam Clin Pharmacol; 2007 Feb; 21(1):81-8. PubMed ID: 17227448 [Abstract] [Full Text] [Related]
26. Effect of ethinylestradiol and epomediol on bile flow and biliary lipid composition in rat. Rodriguez JV, Torres AM, Lunazzi G, Tiribelli C. Biochem Pharmacol; 1992 Mar 17; 43(6):1289-93. PubMed ID: 1562282 [Abstract] [Full Text] [Related]
27. Adenoviral transfer of human aquaporin-1 gene to rat liver improves bile flow in estrogen-induced cholestasis. Marrone J, Lehmann GL, Soria LR, Pellegrino JM, Molinas S, Marinelli RA. Gene Ther; 2014 Dec 17; 21(12):1058-64. PubMed ID: 25208977 [Abstract] [Full Text] [Related]
28. Reversal of ethinylestradiol-induced cholestasis by epomediol in rat. The role of liver plasma-membrane fluidity. Miccio M, Orzes N, Lunazzi GC, Gazzin B, Corsi R, Tiribelli C. Biochem Pharmacol; 1989 Oct 15; 38(20):3559-63. PubMed ID: 2554925 [Abstract] [Full Text] [Related]
29. Beneficial effects of colchicine on 17alpha-ethynylestradiol-induced cholestasis in rats. Zhou ZX, Wang T, Jiang ZZ, Shang J, Liu L, Zhang Y, Zhu D, Huang X, Zhang S, Hu Y, Wang JY, Zhang LY. Arzneimittelforschung; 2011 Oct 15; 61(3):173-9. PubMed ID: 21528642 [Abstract] [Full Text] [Related]
30. The effect of thyroid hormone on bile salt-independent bile flow and Na+, K+ -ATPase activity in liver plasma membranes enriched in bile canaliculi. Layden TJ, Boyer JL. J Clin Invest; 1976 Apr 15; 57(4):1009-18. PubMed ID: 133119 [Abstract] [Full Text] [Related]
31. The effect of complete biliary obstruction on bile secretion. Studies on the mechanisms of postcholestatic choleresis in the rat. Accatino L, Contreras A, Berdichevsky E, Quintana C. J Lab Clin Med; 1981 Apr 15; 97(4):525-34. PubMed ID: 6259265 [Abstract] [Full Text] [Related]
32. Galactosylated Pro-Drug of Ursodeoxycholic Acid: Design, Synthesis, Characterization, and Pharmacological Effects in a Rat Model of Estrogen-Induced Cholestasis. Di Guida F, Pirozzi C, Magliocca S, Santoro A, Lama A, Russo R, Nieddu M, Burrai L, Boatto G, Mollica MP, Sodano F, Lazzarato L, Chegaev K, Meli R, Raso GM, Rimoli MG. Mol Pharm; 2018 Jan 02; 15(1):21-30. PubMed ID: 29140706 [Abstract] [Full Text] [Related]
33. Subcellular pathology of rat liver in cholestasis and choleresis induced by bile salts. 1. Effects of lithocholic, 3beta-hydroxy-5-cholenoic, cholic, and dehydrocholic acids. Miyai K, Richardson AL, Mayr W, Javitt NB. Lab Invest; 1977 Mar 02; 36(3):249-58. PubMed ID: 839737 [Abstract] [Full Text] [Related]
34. Improvement of estradiol 17 beta-D-glucuronide cholestasis by intravenous administration of dimethylethanolamine in the rat. Alvaro D, Angelico M, Cantafora A, Gaudio E, Gandin C, Santini MT, Masella R, Capocaccia L. Hepatology; 1991 Jun 02; 13(6):1158-72. PubMed ID: 1646761 [Abstract] [Full Text] [Related]
35. Intravenous ursodeoxycholic acid reduces cholestasis in parenterally fed newborn piglets. Duerksen DR, Van Aerde JE, Gramlich L, Meddings JB, Chan G, Thomson AB, Clandinin MT. Gastroenterology; 1996 Oct 02; 111(4):1111-7. PubMed ID: 8831607 [Abstract] [Full Text] [Related]
36. Galactosamine prevents ethinylestradiol-induced cholestasis. Crocenzi FA, Pellegrino JM, Catania VA, Luquita MG, Roma MG, Mottino AD, Pozzi EJ. Drug Metab Dispos; 2006 Jun 02; 34(6):993-7. PubMed ID: 16554370 [Abstract] [Full Text] [Related]
37. Inhibition of biliary lipid and protein secretion by cyclosporine A in the rat. Galán AI, Román ID, Muñoz ME, Cava F, Gonzalez-Buitrago JM, Esteller A, Jimenez R. Biochem Pharmacol; 1992 Sep 25; 44(6):1105-13. PubMed ID: 1417934 [Abstract] [Full Text] [Related]
38. Ursodeoxycholate reduces ethinylestradiol glucuronidation in the rat: role in prevention of estrogen-induced cholestasis. Sánchez Pozzi EJ, Crocenzi FA, Pellegrino JM, Catania VA, Luquita MG, Roma MG, Rodríguez Garay EA, Mottino AD. J Pharmacol Exp Ther; 2003 Jul 25; 306(1):279-86. PubMed ID: 12663690 [Abstract] [Full Text] [Related]
39. Tauroursodeoxycholic acid inserts the apical conjugate export pump, Mrp2, into canalicular membranes and stimulates organic anion secretion by protein kinase C-dependent mechanisms in cholestatic rat liver. Beuers U, Bilzer M, Chittattu A, Kullak-Ublick GA, Keppler D, Paumgartner G, Dombrowski F. Hepatology; 2001 May 25; 33(5):1206-16. PubMed ID: 11343250 [Abstract] [Full Text] [Related]